Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland

J Oksi; A Aalto; P Säilä; T Partanen; V Anttila; E Mattila

Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland

J Oksi
, A Aalto
, P Säilä
, T Partanen
, V Anttila
, E Mattila

Research output: Contribution to journal › Article › Scientific › peer-review

35 Citations (Scopus)

Original language	English
Pages (from-to)	1947-1952
Journal	European Journal of Clinical Microbiology and Infectious Diseases
Volume	38
Issue number	10
Publication status	Published - 2019
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 1

Access to Document

https://pubmed.ncbi.nlm.nih.gov/31359254

Cite this

Oksi, J., Aalto, A., Säilä, P., Partanen, T., Anttila, V., & Mattila, E. (2019). Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland. European Journal of Clinical Microbiology and Infectious Diseases, 38(10), 1947-1952. https://pubmed.ncbi.nlm.nih.gov/31359254

@article{88c8ddcd7eb544dc8c0711c2bbf49faf,

title = "Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland",

author = "J Oksi and A Aalto and P S{\"a}il{\"a} and T Partanen and V Anttila and E Mattila",

year = "2019",

language = "English",

volume = "38",

pages = "1947--1952",

journal = "European Journal of Clinical Microbiology and Infectious Diseases",

issn = "0934-9723",

publisher = "Springer",

number = "10",

}

Oksi, J, Aalto, A, Säilä, P, Partanen, T, Anttila, V & Mattila, E 2019, 'Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland', European Journal of Clinical Microbiology and Infectious Diseases, vol. 38, no. 10, pp. 1947-1952. <https://pubmed.ncbi.nlm.nih.gov/31359254>

Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland. / Oksi, J; Aalto, A; Säilä, P et al.
In: European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, No. 10, 2019, p. 1947-1952.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland

AU - Oksi, J

AU - Aalto, A

AU - Säilä, P

AU - Partanen, T

AU - Anttila, V

AU - Mattila, E

PY - 2019

Y1 - 2019

M3 - Article

SN - 0934-9723

VL - 38

SP - 1947

EP - 1952

JO - European Journal of Clinical Microbiology and Infectious Diseases

JF - European Journal of Clinical Microbiology and Infectious Diseases

IS - 10

ER -